WO2002081679A3 - Controlling dna packaging - Google Patents

Controlling dna packaging Download PDF

Info

Publication number
WO2002081679A3
WO2002081679A3 PCT/GB2002/001651 GB0201651W WO02081679A3 WO 2002081679 A3 WO2002081679 A3 WO 2002081679A3 GB 0201651 W GB0201651 W GB 0201651W WO 02081679 A3 WO02081679 A3 WO 02081679A3
Authority
WO
WIPO (PCT)
Prior art keywords
bacteriophages
dna packaging
controlling dna
provides
strains
Prior art date
Application number
PCT/GB2002/001651
Other languages
French (fr)
Other versions
WO2002081679A2 (en
Inventor
Christopher John Arthur Finnis
Margaret Caroline Machin Smith
Original Assignee
Univ Nottingham
Christopher John Arthur Finnis
Margaret Caroline Machin Smith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nottingham, Christopher John Arthur Finnis, Margaret Caroline Machin Smith filed Critical Univ Nottingham
Priority to AU2002242905A priority Critical patent/AU2002242905A1/en
Publication of WO2002081679A2 publication Critical patent/WO2002081679A2/en
Publication of WO2002081679A3 publication Critical patent/WO2002081679A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention provides plasmids, bacteriophages and bacterial strains comprising prophages in which some or all of the cos region has been deleted and replaced in whole or in part by a replacement sequence. The invention also provides methodologies of producing and using such products. Of particular interest are vectors, modified bacteriophages, DNA parkaging components and transducing particles which have broad range infectivity of Actinomycetes bacteria and in particular Streptomyces strains.
PCT/GB2002/001651 2001-04-09 2002-04-09 Controlling dna packaging WO2002081679A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002242905A AU2002242905A1 (en) 2001-04-09 2002-04-09 Controlling dna packaging

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0108830.1 2001-04-09
GB0108830A GB0108830D0 (en) 2001-04-09 2001-04-09 Controlling DNA packaging

Publications (2)

Publication Number Publication Date
WO2002081679A2 WO2002081679A2 (en) 2002-10-17
WO2002081679A3 true WO2002081679A3 (en) 2003-01-16

Family

ID=9912501

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2002/001651 WO2002081679A2 (en) 2001-04-09 2002-04-09 Controlling dna packaging

Country Status (3)

Country Link
AU (1) AU2002242905A1 (en)
GB (1) GB0108830D0 (en)
WO (1) WO2002081679A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9133497B2 (en) 2013-03-13 2015-09-15 GeneWeave Biosciences, Inc. Systems and methods for detection of cells using engineered transduction particles
US9540675B2 (en) 2013-10-29 2017-01-10 GeneWeave Biosciences, Inc. Reagent cartridge and methods for detection of cells

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014160418A2 (en) 2013-03-13 2014-10-02 GeneWeave Biosciences, Inc. Non-replicative transduction particles and transduction particle-based reporter systems
JP2017525377A (en) * 2014-08-25 2017-09-07 ジーンウィーブ バイオサイエンシズ，インコーポレイティド Reporter system based on non-replicating transduced particles and transduced particles
US10351893B2 (en) 2015-10-05 2019-07-16 GeneWeave Biosciences, Inc. Reagent cartridge for detection of cells
US11008602B2 (en) 2017-12-20 2021-05-18 Roche Molecular Systems, Inc. Non-replicative transduction particles and transduction particle-based reporter systems
CN116676274B (en) * 2022-12-21 2024-04-16 暨南大学 Self-deactivatable phage, preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188957A (en) * 1991-02-25 1993-02-23 Stratagene Lambda packaging extract lacking beta-galactosidase activity
WO1995017415A1 (en) * 1993-12-23 1995-06-29 Pharmacia Biotech Inc. In vitro phage lambda dna packaging extract

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188957A (en) * 1991-02-25 1993-02-23 Stratagene Lambda packaging extract lacking beta-galactosidase activity
WO1995017415A1 (en) * 1993-12-23 1995-06-29 Pharmacia Biotech Inc. In vitro phage lambda dna packaging extract

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KOBLER L ET AL: "CONSTRUCTION AND TRANSDUCTION OF A SHUTTLE VECTOR BEARING THE COS SITE OF STREPTOMYCES PHAGE PHI-C31 AND DETERMINATION OF ITS COHESIVE ENDS", FEMS (FEDERATION OF EUROPEAN MICROBIOLOGICAL SOCIETIES) MICROBIOLOGY, vol. 78, no. 2-3, 1991, 1991, pages 347 - 354, XP002219354, ISSN: 0378-1097 *
RODICIO M R ET AL: "NEW DERIVATIVES OF THE STREPTOMYCES TEMPERATE PHAGE PHI-C-31 USEFUL FOR THE CLONING AND FUNCTIONAL ANALYSIS OF STREPTOMYCES DNA", GENE (AMSTERDAM), vol. 34, no. 2-3, 1985, pages 283 - 292, XP001107020, ISSN: 0378-1119 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9133497B2 (en) 2013-03-13 2015-09-15 GeneWeave Biosciences, Inc. Systems and methods for detection of cells using engineered transduction particles
US9546391B2 (en) 2013-03-13 2017-01-17 GeneWeave Biosciences, Inc. Systems and methods for detection of cells using engineered transduction particles
US9540675B2 (en) 2013-10-29 2017-01-10 GeneWeave Biosciences, Inc. Reagent cartridge and methods for detection of cells

Also Published As

Publication number Publication date
GB0108830D0 (en) 2001-05-30
WO2002081679A2 (en) 2002-10-17
AU2002242905A1 (en) 2002-10-21

Similar Documents

Publication Publication Date Title
AU2002258085A6 (en) Non-dairy or dairy containing product
EP1288298A3 (en) TRNA synthetase from Staphylococcus aureus
EP1288299A3 (en) TRNA synthetase
WO2003029394A1 (en) Cleaning agent, antibacterial material, environment clarifying material, functional adsorbent
EP1260587A3 (en) Tyrosyl tRNA synthetase
EP1454138A4 (en) Immunocytokines with modulated selectivity
WO2002057664A3 (en) Bacillus thuringiensis insecticidal proteins
CA2418442A1 (en) Novel helper functions for recombinant vector production
MXPA03008121A (en) 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi.
EP0832975A3 (en) Histidinol dehydrogenase from Staphylococcus aureus
EP2278006A3 (en) Neisserial antigens
WO2002074839A3 (en) Abrasive articles having a polymeric material
NZ532665A (en) Neisseria meningitidis antigens and compositions
AU1367095A (en) Effector proteins of rapamycin
WO1999041368A3 (en) Optimization of immunomodulatory properties of genetic vaccines
HUP0202442A2 (en) Multiple cytokine-antibody complexes
AU2002335788A1 (en) Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources
WO2002081679A3 (en) Controlling dna packaging
WO2004013160A3 (en) Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
AU2002344729A1 (en) Process for preparing protein isolate from milk, whey, colostrum, and the like
HK1056292A1 (en) Method of culturing zooplankton, apparatus for culturing by the same, and culture obtained by the same.
WO2006127822A3 (en) Scytovirin domain 1 related polypeptides
GB0205378D0 (en) Bacterial spores
HK1050877A1 (en) Print media products, methods for making the same and coating formulations
WO2002066650A3 (en) Streptococcus pyogenes polypeptides and corresponding dna fragments

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP